Published 30day Notice

lotter on DSK11XQN23PROD with NOTICES1

Federal Register / Vol. 90, No. 95 / Monday, May 19, 2025 / Notices
Group; Vaccines Against Infectious Diseases
Study Section.
Date: June 16–17, 2025.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jian Wang, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
MSC 7812, Bethesda, MD 20892, (301) 213–
9853, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 23–
077: Collaborative Program Grant for
Multidisciplinary Teams (RM1).
Date: June 16, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, [email protected].
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Basic
Mechanisms of Diabetes and Metabolism
Study Section.
Date: June 16–17, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Victoria Martinez Virador,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–4703, victoria.virador@
nih.gov.
Name of Committee: Applied Immunology
and Disease Control Integrated Review
Group; Transmission of Vector-Borne and
Zoonotic Diseases Study Section.
Date: June 16–17, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Haruhiko Murata, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
National Institutes of Health, Bethesda, MD
20892, (301) 594–3245, [email protected].
Name of Committee: Cell Biology
Integrated Review Group; Maximizing

VerDate Sep<11>2014

18:25 May 16, 2025

Jkt 265001

Investigators’ Research Award C Study
Section.
Date: June 16–17, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8559, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 13, 2025.
Sterlyn H. Gibson,
Program Specialist, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–08890 Filed 5–16–25; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Data Use
Certification for the NIH Brain
Development Cohorts (NBDC),
(National Institute on Drug Abuse)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
SUMMARY:

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

21323

proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Elizabeth A.
Hoffman, Associate Director, Division of
Extramural Research, National Institute
on Drug Abuse, 3WFN Room 09C75
MSC 6021, Gaithersburg, MD 20877, or
call non-toll-free number (301) 594–
2265 or Email your request, including
your address to: elizabeth.hoffman@
nih.gov.
This
information collection was previously
published in the Federal Register on
November 12, 2024, (89 FR 89019) and
allowed 60 days for public comment. No
public comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institute on Drug Abuse
(NIDA), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the NIH has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
Proposed Collection: Data Use
Certification for the NIH BRAIN
Development Cohorts (NBDC), (NIDA)
REVISION 0925–0780, expiration date
10/31/2026, National Institute on Drug
Abuse (NIDA), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of this
information collection is to collect from
Recipients a brief description of their
research project to submit to the NIH
Brain Development Cohorts (NBDC)
data repository to gain access to NBDC
Study data. Recipients who plan to
conduct research studies specifically on
American Indian/Alaska Native (AI/AN)
populations must submit an additional
data use statement. The purpose of this
revision is to clarify inclusion of the
HBCD Study, and to request a progress
report statement at the time of renewal.
Burden levels remain unchanged.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,000.

SUPPLEMENTARY INFORMATION:

E:\FR\FM\19MYN1.SGM

19MYN1

21324

Federal Register / Vol. 90, No. 95 / Monday, May 19, 2025 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Average time
per response
(in hours)

Total annual
burden hour

Individuals (standard DUC form) .....................................................................
Individuals (additional AI/AN DUC form when needed) ..................................

1,800
200

1
1

1
1

1,800
200

Total ..........................................................................................................

........................

2,000

........................

2,000

Usha R Charya,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2025–08893 Filed 5–16–25; 8:45 am]

National Institutes of Health

BILLING CODE 4140–01–P

National Heart, Lung, and Blood
Institute; Amended Notice of Meeting

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Advisory Council, June 11,
2025, 10:00 a.m. to June 11, 2025, 10:20
a.m., Porter Neuroscience Research
Center, Building 35A, Bethesda, MD
20892 which was published in the
Federal Register on April 2, 2025, 90 FR
14453.
The National Heart, Lung, and Blood
Advisory Council closed meeting is
being amended due to a change in the
meeting format from virtual to regular.
The new meeting location is located at
the Porter Neuroscience Research
Center, Building 35A, 35A Convent
Drive, Bethesda, MD 20892. The
meeting is partially closed to the public.

National Eye Institute; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Eye Council, June 13, 2025, 8:30 a.m. to
June 13, 2025, 5 p.m., National Eye
Institute, 6700B Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
March 31, 2025, 90 FR 14266.
This meeting is being amended to
change the Contact Person from
Kathleen C. Anderson to Hyo-Jung Anna
Han. Dr. Han’s contact information is as
follows: Hyo-Jung Anna Han, Ph.D.,
Acting Director, Division of Extramural
Activities, National Eye Institute, NIH,
6700B Rockledge Drive, Bethesda, MD
20892, [email protected], (301) 496–
2234.
The timeframe for the meeting is also
being amended. The open session will
change from 8:30 a.m.–2:30 p.m. to
10:10 a.m.–1:15 p.m. The closed session
will change from 2:40 p.m.–5 p.m. to
1:15 p.m.–3 p.m. The meeting format is
changing from Hybrid to Virtual. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov/watch=56697). The
meeting is partially closed to the public.
Dated: May 13, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–08828 Filed 5–16–25; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

18:25 May 16, 2025

Jkt 265001

20892. The meeting is partially Closed
to the public.
Dated: May 13, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–08827 Filed 5–16–25; 8:45 am]

National Institutes of Health

lotter on DSK11XQN23PROD with NOTICES1

Number of
responses per
respondent

Dated: May 13, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–08826 Filed 5–16–25; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Advisory Council, June 11,
2025, 10:20 a.m. to June 11, 2025, 4
p.m., Porter Neuroscience Research
Center, Building 35A, Bethesda, MD
20892 which was published in the
Federal Register on April 2, 2025, 90 FR
14453.
The National Heart, Lung, and Blood
Advisory Council open meeting is being
amended due to a change in the meeting
format from virtual to regular. The new
meeting location is located at the Porter
Neuroscience Research Center, Building
35A, 35A Convent Drive, Bethesda, MD

PO 00000

Frm 00055

Fmt 4703

Sfmt 4703

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Learning, Memory
and Decision Neuroscience Study Section.
Date: June 17–18, 2025.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Roger Janz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8515, [email protected].
Name of Committee: Aging and
Neurodegeneration Integrated Review Group;
Cognitive Disorders and Brain Aging Study
Section.
Date: June 17–18, 2025.
Time: 8:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.

E:\FR\FM\19MYN1.SGM

19MYN1